Dine Brands Global, Inc. DIN
Set alert
35.04 USD -1.45 -3.97%
As of Nov 3, 1:00 PM ET
35.02 Day range 36.67
23.23 52-week range 39.68
- YTD
- +9.02%
- 1 year
- +44.97%
- Open
- 36.50
- Prev close
- 36.49
- Mkt cap
- 443.58M
- Vol
- 174.94K
- Avg vol
- 492.90K
- EPS
- 0.61
- P/E
- 57.44
- Div yield
- 2.16%
More statistics
- Low
- 35.02
- High
- 36.67
- Forward P/E
- 4.97
- Beta
- 1.73
- Short ratio
- 3.43
- Inst. own
- 101.07%
- Dividend
- 2.04
- Ex-div date
- Dec 19, 2024
- 50-d avg
- 32.45
- 200-d avg
- 36.28
- 1y target
- 41.43
5Y chart
Events in this range
- Dec 17, 2021Dividend: 0.4
- Mar 18, 2022Dividend: 0.46
- Jun 16, 2022Dividend: 0.51
- Sep 19, 2022Dividend: 0.51
- Dec 19, 2022Dividend: 0.51
- Jan 6, 2023Dividend: 0.51
- Mar 17, 2023Dividend: 0.51
- Jun 16, 2023Dividend: 0.51
- Aug 3, 2023Earnings: 1.82; estimate 1.53; surprise 18.95%
- Sep 18, 2023Dividend: 0.51
- Nov 1, 2023Earnings: 1.46; estimate 1.32; surprise 10.61%
- Dec 19, 2023Dividend: 0.51
- Feb 28, 2024Earnings: 1.4; estimate 1.12; surprise 25%
- Mar 19, 2024Dividend: 0.51
- May 8, 2024Earnings: 1.33; estimate 1.59; surprise -16.35%
- Jun 20, 2024Dividend: 0.51
- Aug 7, 2024Earnings: 1.71; estimate 1.65; surprise 3.64%
- Sep 20, 2024Dividend: 0.51
- Nov 4, 2024Downgrade: CL King · Buy → Neutral
- Nov 6, 2024Earnings: 1.44; estimate 1.33; surprise 8.27%
- Nov 7, 2024Rating: Wedbush · Outperform → Outperform
- Nov 7, 2024Rating: Barclays · Overweight → Overweight
- Nov 7, 2024Rating: UBS · Buy → Buy
- Nov 15, 2024Rating: Wedbush · Outperform → Outperform
- Nov 18, 2024Rating: Piper Sandler · Neutral → Neutral
- Dec 20, 2024Dividend: 0.51
- Mar 17, 2025Dividend: 0.51
- Jun 20, 2025Dividend: 0.51
- Sep 19, 2025Dividend: 0.51
- Dec 23, 2025Dividend: 0.19
- Mar 18, 2026Dividend: 0.19
- Jun 24, 2026Dividend: 0.19
- Sep 16, 2026Dividend: 0.19
Signals (98)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 2026 | 1 day ago |
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| MACD: Buy Signal | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
Newest 20 of 98.
Analyst view
Price target (mean) 41.43 +18.2% upside
Now 35.04
- Target (low)
- 36.00
- Target (mean)
- 41.43
- Target (high)
- 47.00
Ratings (0m) 9 4 buy · 5 hold · 0 sell
- Strong buy1
- Buy3
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.35 | 1.32 – 1.40 | 1.40 | -3.2% | 201.09M | -2.5% | 9 |
| Next quarter | 1.42 | 1.28 – 1.51 | 1.33 | +7.0% | 206.11M | -0.1% | 5 |
| Current year | 5.84 | 5.80 – 5.88 | 6.65 | -12.2% | 809.04M | -2.7% | 9 |
| Next year | 5.94 | 5.23 – 6.26 | 5.84 | +1.7% | 815.12M | +0.8% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 18, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Nov 15, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Nov 7, 2024 | UBS | Maintained | Buy | Buy |
| Nov 7, 2024 | Barclays | Maintained | Overweight | Overweight |
| Nov 7, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Nov 4, 2024 | CL King | Downgrade | Buy | Neutral |
| Oct 29, 2024 | Benchmark | Reiterated | — | Hold |
| Oct 18, 2024 | Keybanc | Maintained | Overweight | Overweight |
| Oct 4, 2024 | Truist Securities | Downgrade | Buy | Hold |
| Oct 1, 2024 | Wedbush | Upgrade | Neutral | Outperform |
| Aug 8, 2024 | Barclays | Maintained | Overweight | Overweight |
| Aug 8, 2024 | Keybanc | Maintained | Overweight | Overweight |
| Aug 8, 2024 | Benchmark | Downgrade | Buy | Hold |
| Aug 8, 2024 | UBS | Maintained | Buy | Buy |
| Aug 8, 2024 | Truist Securities | Maintained | Buy | Buy |
| Aug 8, 2024 | Wedbush | Maintained | Neutral | Neutral |
| Jul 30, 2024 | Wedbush | Maintained | Neutral | Neutral |
| Jul 9, 2024 | Keybanc | Maintained | Overweight | Overweight |
| May 9, 2024 | Barclays | Maintained | Overweight | Overweight |
| May 9, 2024 | Wedbush | Maintained | Neutral | Neutral |
| May 9, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Apr 9, 2024 | Keybanc | Maintained | Overweight | Overweight |
| Mar 4, 2024 | Benchmark | Maintained | Buy | Buy |
| Feb 29, 2024 | Truist Securities | Maintained | Buy | Buy |
| Feb 29, 2024 | Barclays | Maintained | Overweight | Overweight |
| Feb 29, 2024 | Wedbush | Maintained | Neutral | Neutral |
| Jan 3, 2024 | Barclays | Maintained | Overweight | Overweight |
| Dec 15, 2023 | Keybanc | Maintained | Overweight | Overweight |
| Nov 3, 2023 | Truist Securities | Maintained | Buy | Buy |
| Nov 2, 2023 | Piper Sandler | Maintained | Neutral | Neutral |